Dual COX/5-LOX inhibition by isorhamnetin-3-O-glucoside from Anthyllis cytisoides: An integrated chemical-enzymatic-computational study
| Author | Bouammali, Haytham |
| Author | Khibech, Oussama |
| Author | Fraj, Elmehdi |
| Author | Elbouzidi, Amine |
| Author | Bekkouch, Ayoub |
| Author | Bourhou, Chaymae |
| Author | Zughaier, Susu M. |
| Author | Merzouki, Mohammed |
| Author | Hassiba, Maryam |
| Author | jaouani, Hanane |
| Author | Bouammali, Boufelja |
| Author | Challioui, Allal |
| Author | Touzani, Rachid |
| Available date | 2026-01-28T07:29:25Z |
| Publication Date | 2026-03-01 |
| Publication Name | Journal of Ethnopharmacology |
| Identifier | http://dx.doi.org/10.1016/j.jep.2025.120982 |
| Citation | Bouammali, Haytham, Oussama Khibech, Elmehdi Fraj, Amine Elbouzidi, Ayoub Bekkouch, Chaymae Bourhou, Susu M. Zughaier et al. "Dual COX/5-LOX Inhibition by Isorhamnetin-3-O-Glucoside from Anthyllis cytisoides: An Integrated Chemical-Enzymatic-Computational Study." Journal of Ethnopharmacology (2025): 120982. |
| ISSN | 03788741 |
| Abstract | Ethnopharmacological relevanceAnthyllis cytisoides L. is a forage shrub native to the western Mediterranean basin, traditionally used in folk medicine to treat respiratory and gastrointestinal inflammation. However, its polar phytochemical profile and the underlying enzyme-level anti-inflammatory mechanisms involving COX-1/COX-2 and 5-LOX remain weakly documented. Aim of the studyTo integrate chemical, enzymatic, and computational evidence that links the constituents of A. cytisoides L to COX-1, COX-2, and 5-LOX targets, thereby contextualizing the species’ ethnopharmacological indications. Materials and methodsThe aerial parts were subjected to polarity-guided fractionation followed by LC–HRMS profiling. From the methanolic fraction, a flavonol glycoside was isolated and structurally elucidated as isorhamnetin-3-O-glucoside (I3OG) using ESI–MS, IR spectroscopy, and 1D/2D NMR analyses. Enzymatic inhibition of COX-1, COX-2, and 5-LOX was assessed (COX via PGE2 radioimmunoassay; 5-LOX via FOX assay at 560 nm), and IC50 values were calculated using four-parameter logistic regression (95 % CI). Molecular docking (COX-1: 1EQG; COX-2: 5F19; 5-LOX: 6NCF) and 100-ns molecular dynamics simulations (GROMACS) were also performed. ResultsI3OG was successfully identified and purified from A. cytisoides. It inhibited COX-1, COX-2, and 5-LOX with IC50 values of 10.65 ± 1.02, 15.09 ± 0.84, and 15.24 ± 1.18 μg/mL (≈22.3, 31.6, and 31.9 μM), respectively, surpassing the inhibitory activity of the crude extracts for all targets. Docking studies and 100-ns MD simulations confirmed stable interactions with each enzyme, in agreement with the experimental inhibition ranking (COX-1 > COX-2 ≈ 5-LOX). ConclusionI3OG emerges as a promising dual COX/5-LOX candidate from A. cytisoides, providing a coherent link between detailed phytochemical analysis, enzymatic inhibition, and atomistic binding mechanisms. Although selectivity and safety considerations fall outside the scope of this enzyme-focused study, the findings highlight A. cytisoides as a valuable source of multitarget anti-inflammatory scaffolds and support SAR-driven optimization and formulation strategies aimed at enhancing bioactivity. |
| Language | en |
| Publisher | Elsevier |
| Subject | Anthyllis cytisoides L. I3OG COX/5-LOX inhibition LC-HRMS Molecular docking & MD |
| Type | Article |
| Volume Number | 358 |
| ESSN | 1872-7573 |
Check access options
Files in this item
This item appears in the following Collection(s)
-
Medicine Research [2052 items ]


